Show item record

dc.contributor.authorRose, Christopher
dc.contributor.authorFelipo, Vicente
dc.date.accessioned2013-04-23T19:04:37Z
dc.date.available2013-04-23T19:04:37Z
dc.date.issued2005-12
dc.identifier.urihttp://hdl.handle.net/1866/9576
dc.description.sponsorshipCR: CIHR-post-doctoral fellowen
dc.subjectAmmoniaen
dc.subjectAmmoniacen
dc.subjectChronic liver failureen
dc.subjectGlutamate-ammonia ligaseen
dc.subjectGlutamine synthetaseen
dc.subjectHepatic encephalopathyen
dc.subjectMaladie du foie en phase terminaleen
dc.subjectMonoxyde d'azoteen
dc.subjectNitric oxideen
dc.titleLimited capacity for ammonia removal by brain in chronic liver failure: potential role of nitric oxide
dc.typeArticleen
dc.contributor.affiliationUniversité de Montréal. Faculté de médecinefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. Centre de recherche du CHUMfr
dc.identifier.doi10.1007/s11011-005-7906-4
dcterms.abstractChronic liver failure leads to hyperammonemia and consequently increased brain ammonia concentrations, resulting in hepatic encephalopathy. When the liver fails to regulate ammonia concentrations, the brain, devoid of a urea cycle, relies solely on the amidation of glutamate to glutamine through glutamine synthetase, to efficiently clear ammonia. Surprisingly, under hyperammonemic conditions, the brain is not capable of increasing its capacity to remove ammonia, which even decreases in some regions of the brain. This non-induction of glutamine synthetase in astrocytes could result from possible limiting substrates or cofactors for the enzyme, or an indirect effect of ammonia on glutamine synthetase expression. In addition, there is evidence that nitration of the enzyme resulting from exposure to nitric oxide could also be implicated. The present review summarizes these possible factors involved in limiting the increase in capacity of glutamine synthetase in brain, in chronic liver failure.en
dcterms.languageengen
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleMetabolic brain disease
oaire.citationVolume20
oaire.citationIssue4
oaire.citationStartPage275
oaire.citationEndPage283


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.